CG
BIVV

Cutler Group’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Cutler Group’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,700
Closed -$2K – 5806
2017
Q4 		$2K Sell
1,700
-8,300
-83% -$454K ﹤0.01% 4319
2017
Q3 		$9K Sell
10,000
-33,800
-77% -$1.98M ﹤0.01% 3949
2017
Q2 		$23K Buy
43,800
+18,600
+74% +$1.06M ﹤0.01% 3302
2017
Q1 		$20K Buy
+25,200
New +$1.24M ﹤0.01% 3353

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Cutler Group's BIVV Position: Q1 2018 in Review

Cutler Group sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 2,784 shares — an estimated $150K sold.

Cutler Group first reported a position in BIVV in Q1 2017 and held it in 4 quarters. The position peaked at $2.53M in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Cutler Group reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Cutler Group sold 2,784 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $150K.
  • Cutler Group first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 4 quarters.
  • Cutler Group's Bioverativ Inc. Common Stock position peaked at $2.53M in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Cutler Group's 13F filing for Q1 2018, filed 11 May 2018.